Amplius Wealth Advisors LLC Has $572,000 Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Amplius Wealth Advisors LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 978 shares of the healthcare conglomerate’s stock after purchasing an additional 31 shares during the quarter. Amplius Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $572,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of UNH. Kathleen S. Wright Associates Inc. acquired a new stake in UnitedHealth Group during the third quarter worth $27,000. Global Wealth Strategies & Associates increased its stake in UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 32 shares during the period. Macroview Investment Management LLC lifted its stake in UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 47 shares during the period. West Financial Advisors LLC bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at approximately $32,000. Finally, Delos Wealth Advisors LLC lifted its position in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 53 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 2.7 %

NYSE:UNH opened at $571.30 on Thursday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $608.63. The stock’s fifty day simple moving average is $584.21 and its 200-day simple moving average is $532.84. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $527.55 billion, a P/E ratio of 37.88, a P/E/G ratio of 1.69 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. UnitedHealth Group’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter last year, the firm earned $6.56 EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 27.68 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.47%. UnitedHealth Group’s payout ratio is 55.70%.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of analyst reports. TD Cowen lifted their price objective on UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Royal Bank of Canada reduced their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday. Bank of America reduced their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday. Robert W. Baird boosted their price objective on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Finally, StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Wednesday. One investment analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $615.16.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.